Short Interest in Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) Declines By 42.3%

Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) was the recipient of a large decline in short interest in August. As of August 31st, there was short interest totalling 11,300 shares, a decline of 42.3% from the August 15th total of 19,600 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Kissei Pharmaceutical Stock Performance

Shares of Kissei Pharmaceutical stock opened at $18.81 on Friday. Kissei Pharmaceutical has a twelve month low of $17.71 and a twelve month high of $19.90. The business has a 50-day moving average price of $18.81 and a 200 day moving average price of $18.81.

About Kissei Pharmaceutical

Kissei Pharmaceutical Co, Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan. The company offers Kalogra tablets, for the treatment of ulcerative colitis; Tabuneos capsules for the treatment of microscopic polyangiitis and granulomatous polyangiitis; Minirin Melt OD tablets; Malizeb tablets; Tavaris tablets for the treatment of chronic idiopathic thrombocytopenic purpura; Beova tablets for the treatment of overactive bladder treatment; and Darbepoetin Alfa BS injection JCR for the treatment of renal anemia.